Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-13

Genpact Ltd (G) Stock Forecast Oct. 13, 2026

Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE

Follow Unlock full AI forecasts
Rating · 90D Neutral Alpha
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Middle 30% of 5379 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $5.92B mid-cap · #2 of 30 peers
Summary

Genpact Ltd (G) stock forecast summary

On Oct. 13, 2026, G is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5379 stocks scored that day.

Genpact Ltd is a mid-cap company with a market capitalization of $5.92B. It ranks number 2 by market capitalization among the 30 Services-Management Consulting Services issuers in our coverage with a current forecast. Its P/E Ratio of 10.16x is the lowest of the 11 peers that report one.

A per-ticker accuracy statistic for G is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, G included.

Follow G free
Price

G price chart and AI forecast

G
Cross-section · 2026-10-13

How G ranks among 5379 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Genpact Ltd (G) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Management Consulting Services peers listed below that report each metric.

Valuation & Market

MetricGIndustry medianRank
Market Cap $5.92B $209M 2/30
P/E Ratio 10.16x 17.71x 11/11
P/B Ratio 2.27x 2.88x 18/26
Dividend Yield 2.06% 2.06% 5/8
EPS $3.24 – –
Book Value/Share $15.50 – –
Revenue/Share $31.24 – –
FCF/Share $3.40 – –

Profitability & Margins

MetricGIndustry medianRank
ROE 22.4% 6.7% 7/24
ROA 10.8% 0.0% 4/32
ROIC 18.0% 7.0% 10/29
Gross Margin 36.5% 36.4% 12/24
Operating Margin 14.8% 1.8% 3/30
Net Margin 11.1% 1.4% 3/28
EBT Margin 14.5% 1.6% 3/31
Tax Rate 23.6% – –

Financial Health

MetricGIndustry medianRank
Current Ratio 2.00x 1.60x 12/34
D/E Ratio 1.08x 1.00x 15/31
Financial Leverage 2.08x 2.00x 15/31
Interest Coverage 6.4x -2.3x 7/30
Working Capital $1.08B $15M 2/34

Cash Flow

MetricGIndustry medianRank
Operating Cash Flow $644M $1M 2/36
Free Cash Flow $572M $17M 1/17
Capital Spending -$72M -$10M 17/17
OCF Growth YoY -0.8% -0.8% 8/15
FCF Growth YoY 1.1% -11.9% 5/13
FCF/Sales 10.9% 6.7% 3/17
CapEx/Sales 1.4% 1.1% 8/17

Operational Efficiency

MetricGIndustry medianRank
Asset Turnover 0.97x 0.97x 12/25
Receivables Turnover 3.7x 7.7x 17/19
Fixed Assets Turnover 28.5x 29.0x 11/19
Days Sales Outstanding 98 days 46 days 3/20
Payables Period 2 days 38 days 21/21

Income Statement

MetricGIndustry medianRank
Total Revenue $5.25B $176M 1/25
Operating Income $778M $0.00M 2/35
Net Income $582M $0.00M 2/32
SG&A Expense $1.10B $37M 1/18
Cost of Goods Sold $3.34B $36M 3/27

Dividend & Shareholder Information

MetricGIndustry medianRank
Dividends Per Share $0.72 – –
Payout Ratio 22.2% 60.0% 6/7
Shares Outstanding 168M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$2.17B40.1% of assets
Cash & Short-term Investments$517M9.6% of assets
Accounts Receivable$1.40B25.9% of assets
Total Liabilities$2.81B51.9% of assets
Short-term Debt$1.07B19.8% of assets
Quarterly Financial Reports

G quarterly financials and insider trading

Industry Peers · Services-Management Consulting Services

Genpact Ltd (G) industry peers

Companies classified under the same SEC industry code as Genpact Ltd (Services-Management Consulting Services): 43 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
G Genpact Ltd ▶ $5.92B 10.2x 2.3x
BAH Booz Allen Hamilton Holding Corp ▼ $8.70B 11.2x 7.2x
FCN Fti Consulting, Inc ▶ $3.81B 15.1x 2.9x
EXPO Exponent Inc ▲ $3.39B 30.3x 11.7x
HURN Huron Consulting Group Inc. ▶ $2.86B 24.4x 6.4x
ASTH Astrana Health, Inc. ▲ $2.11B 52.1x 2.5x
ICFI Icf International, Inc. ▶ $1.57B 17.7x 1.5x
BWMN Bowman Consulting Group Ltd. ▼ $741M 100.4x 2.9x
RMR Rmr Group Inc. ▲ $588M – 2.5x
ROMA Roma Green Finance Ltd ▶ $521M – 6.1x
ONT Onterris, Inc. ▶ $466M – 1.1x
PPHC Public Policy Holding Company, Inc. ▲ $320M – 2.9x
HCKT Hackett Group, Inc. ▲ $286M 17.0x 4.2x
III Information Services Group Inc. ▲ $285M 24.4x 3.0x
TSSI Tss, Inc. ▶ $249M 14.3x 3.1x
PHCI Panamera Holdings Corp ▼ $169M – –
MHH Mastech Digital, Inc. ▲ $78M – 0.9x
GFLT Genflat Holdings, Inc. ▼ $69M – 10.1x
VDTA Vertical Data Inc. ▼ $56M – –
CTM Castellum, Inc. ▲ $56M – 1.6x
EUBG Entrepreneur Universe Bright Group ▼ $43M – 4.1x
RYOJ Ryojbaba Co., Ltd. ▼ $34M – 10.7x
AERT Aeries Technology, Inc. ▲ $32M – –
ACCS Access Newswire Inc. ▶ $18M – 0.6x
GRNQ Greenpro Capital Corp. ▼ $14M – 0.7x
PBSV Pharma-Bio Serv, Inc. ▲ $10M – 0.9x
CISO Ciso Global, Inc. ▲ $7M – 0.6x
ELVG Elvictor Group, Inc. ▶ $5M – 8.7x
BDTB Bodhi Tree Biotechnology Inc ▼ $5M – 368.1x
HSTA Hestia Insight Inc. ▼ $840K – –
AUC Atif Holdings Ltd ▶ N/A – –
DFNS T3 Defense Inc. ▼ N/A – –
GIB Cgi Inc ▶ N/A – –
GXXM Gex Management, Inc. ▼ N/A – –
IVHI Invech Holdings, Inc. ▲ N/A – –
LEEN Leopard Energy, Inc. ▼ N/A – –
LICN Lichen International Ltd ▼ N/A – –
NORD Nordicus Partners Corp ▲ N/A – –
RTB Rtb Digital, Inc. ▶ N/A – –
SATT Sativus Tech Corp. ▼ N/A – –
SSHT Ssht S&T Group Ltd. ▼ N/A – –
THRC Havana Roasters Coffee Companies, Inc. ▼ N/A – –
WYGC Wenyuan Group Corp. ▼ N/A – –

Where G sits on the market map

Trade & Services · Services-Management Consulting Services
Explore the map →
News

Genpact Ltd (G) stock news

source: Nasdaq

Looking at the universe of stocks we cover at Dividend Channel, on 12/9/24, Genpact Ltd (Symbol: G) will trade ex-dividend, for its quarterly dividend of $0.1525, payable on 12/23/24. As a percentage ...

source: Yahoo Finance

Genpact Ltd (NYSE:G) recently announced a total dividend of $0.19 per share, with the ex-dividend date set for 2026-09-10. This amount includes a $0.19 per share cash dividend payable on 2026-09-24.

More news available

Sign up free to read all 12 news articles and stay updated on market developments.

Sign Up Free to Read More
FAQ

Genpact Ltd (G) stock forecast FAQ

What is the Genpact Ltd (G) stock forecast?

On Oct. 13, 2026, G is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5379 stocks scored that day.

How accurate are Genpact Ltd stock predictions?

A per-ticker accuracy statistic for G is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Genpact Ltd forecasts updated?

Genpact Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Which companies are Genpact Ltd's industry peers?

43 issuers in our coverage, G included, share the SEC industry code Services-Management Consulting Services. The largest are: Booz Allen Hamilton Holding Corp (BAH), Fti Consulting, Inc (FCN), Exponent Inc (EXPO), Huron Consulting Group Inc. (HURN), Astrana Health, Inc. (ASTH), Icf International, Inc. (ICFI).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.